Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-04-000303
Filing Date
2004-03-29
Accepted
2004-03-29 16:12:58
Documents
9
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K YEAR ENDED 12-31-03 a97498e10vk.htm 10-K 934849
3 EXHIBIT 10.08 a97498exv10w08.txt EX-10.08 33875
4 EXHIBIT 21.01 a97498exv21w01.txt EX-21.01 380
5 EXHIBIT 23.01 a97498exv23w01.txt EX-23.01 727
6 EXHIBIT 31.1 a97498exv31w1.txt EX-31.1 3328
7 EXHIBIT 31.2 a97498exv31w2.txt EX-31.2 3344
8 EXHIBIT 32 a97498exv32.txt EX-32 2404
9 GRAPHIC a97498a9749800.gif GRAPHIC 7290
10 GRAPHIC a97498a9749801.gif GRAPHIC 6952
  Complete submission text file 0000936392-04-000303.txt   995498
Mailing Address
Business Address 2110 RUTHERFORD ROAD CARLSBAD CA 92008 7604944200
CANCERVAX CORP (Filer) CIK: 0001131907 (see all company filings)

EIN.: 522243564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50440 | Film No.: 04696363
SIC: 2836 Biological Products, (No Diagnostic Substances)